The Transformation of Medtech through AI and LLMs
In this keynote, Yvonne Hasler will give us an overview, what new technology moves forward the pharma, medical device and medtech industry by outlining the new developments in
- Smart Devices Supporting Individual Lifestyle such as Adaptations such as the Evolution of Smart Devices, Personalized Health Recommendations, Beyond Physical Health
- Early Diagnosis of Chronic Diseases such as Blood-Based Alzheimer’s Diagnostic, the Role of AI in Blood-Based Diagnostics, Preventive Measures for Alzheimer’s
- Preventive Medicine for the Cardiovascular System such as for Age and Heart Health, Improved Risk Classification, Personalized Preventive Measures
- Prosthetics That Can Feel with the Evolution of Prosthetics, AI’s Role in Sensory Prosthetics, Enhancing User Experience leading to Real-Life Impact
- Integration of AI in Healthcare Services in Telemedicine and Virtual Health Assistants, Predictive Analytics for Personalized Treatment, Enhancing Clinical Decision-Making
- The Future of Medtech with AI and LLMs by AI-Driven Drug Discovery and Remote Patient Monitoring
Yvonne Hasler – REIMBURSEMENT ANALYST BEI MEDTRONIC
Yvonne Hasler has been involved in the diabetes sector since 1997, accumulating over 20 years of experience in the pharmaceutical industry, particularly in marketing and project management. She has also dedicated more than a decade to Medtech Reimbursement. The advancements in computer and sensor technology have consistently amazed Yvonne Hasler, making her appreciative of witnessing the dawn of personalized therapy in her work with automated insulin treatments.